Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Research and development investments of Celltrion Pharm, Inc. from 2013 to 2017
(in billion South Korean won)
Celltrion R&D investment South Korea 2013-2017
The statistic depicts the investments in research and development of the South Korean biopharmaceutical company Celltrion Pharm, Inc. from 2013 to 2017. In 2017, the R&D investments of Celltrion amounted to around 227 billion South Korean won, decreased from about 263 billion won in the previous year.
Research and development investments of Celltrion Pharm, Inc. from 2013 to 2017
(in billion South Korean won)
Investments in billion South Korean won
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

September 2018

Region

South Korea

Survey time period

2013 to 2017

Supplementary notes

Note: 1,000 South Korean won equal 0.88 U.S. dollars and 0.78 euros (as of April 2019).

Celltrion R&D investment South Korea 2013-2017
The statistic depicts the investments in research and development of the South Korean biopharmaceutical company Celltrion Pharm, Inc. from 2013 to 2017. In 2017, the R&D investments of Celltrion amounted to around 227 billion South Korean won, decreased from about 263 billion won in the previous year.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.